Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H13N3O4S |
Molecular Weight | 247.272 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
InChI
InChIKey=HJLSLZFTEKNLFI-UHFFFAOYSA-N
InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3
Molecular Formula | C8H13N3O4S |
Molecular Weight | 247.272 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:20:29 UTC 2023
by
admin
on
Sat Dec 16 16:20:29 UTC 2023
|
Record UNII |
033KF7V46H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 530.41
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-ATC |
J01RA11
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-ATC |
A02BD09
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-VATC |
QJ01XD02
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-ATC |
J01RA13
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
NDF-RT |
N0000175435
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
FDA ORPHAN DRUG |
155402
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-VATC |
QP51AA02
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
LIVERTOX |
NBK548538
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-ATC |
J01XD02
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
WHO-ATC |
P01AB02
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
NDF-RT |
N0000007663
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
NDF-RT |
N0000007663
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
||
|
FDA ORPHAN DRUG |
173603
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1220
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
m10874
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000092535
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
C890
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
2653
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
5479
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
DB00911
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
SUB11074MIG
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
033KF7V46H
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
033KF7V46H
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
TINIDAZOLE
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
D014011
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
2671
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
243-014-4
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
19387-91-8
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
758189
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
1667520
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
DTXSID4023676
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
10612
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | RxNorm | ||
|
7362
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY | |||
|
Tinidazole
Created by
admin on Sat Dec 16 16:20:30 UTC 2023 , Edited by admin on Sat Dec 16 16:20:30 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
EXCRETED UNCHANGED |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
The hydroxy metabolite of tinidazole was similarly more active than its parent compound.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||